Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.147
+0.197 (4.98%)
Oct 27, 2026, 2:50 PM EDT - Market open
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Coya Therapeutics the 40,716th largest employer in the world and 6,162nd in the United States.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,002,393
Profits / Employee
-$2,708,703
Market Cap
97.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - |
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 2 | 33.33% |
| Dec 31, 2022 | 6 | 0 | - |
| Sep 30, 2022 | 6 | 0 | - |
| Jun 30, 2022 | 6 | - | - |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 142 |
| Inovio Pharmaceuticals | 112 |
| ImmuCell | 73 |
| Tenaya Therapeutics | 70 |
| PMV Pharmaceuticals | 54 |
| Milestone Pharmaceuticals | 38 |
| Genelux | 26 |
| NeurAxis | 24 |
COYA News
- 13 days ago - Coya Therapeutics to initiate OLE of Phase 2/3 ALSTARS trial of COYA 302 - TheFly
- 13 days ago - Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS - Business Wire
- 13 days ago - Coya Therapeutics Slides: Investor presentation - Filings
- 14 days ago - Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference - Business Wire
- 22 days ago - Coya announces full enrollment in Phase 2/3 ALSTARs trial of COYA 302 - TheFly
- 22 days ago - Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS - Business Wire
- 6 weeks ago - Coya Therapeutics announces 100th patient enrolled in Phase 2/3 ALSTARS trial - TheFly
- 6 weeks ago - Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS - Business Wire